Skip to content

Clinical trials

Observational Weight Gain trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Observational Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20071
20082
20091
20102
20151
20171
20181
20202
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting1
Enrolling by invitation1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Pennington Biomedical Research Center2
Washington University School of Medicine2
Azur Pharma, Inc1
Christopher C. Thompson, MD, MSc1
Milton S. Hershey Medical Center1
National Institute on Drug Abuse (NIDA)1
Oregon Research Institute1
Rush University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain21
Obesity7
Psychotic Disorders3
Weight Loss3
Insulin Resistance2
Metabolic Syndrome2
Overweight2
Schizophrenia2
Abdominal Pain1
Anastomotic Leak1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.